[{"NetIncomeLoss_1_Q2_USD":-26818000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":168000.0,"PaymentsToAcquireInvestments_2_Q2_USD":40000000.0,"PurchaseObligation_0_Q2_USD":136000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-3892000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.006,"EquitySecuritiesFvNiCost_0_Q2_USD":125000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":175292764.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":102000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.904,"AccruedLiabilitiesCurrent_0_Q2_USD":12862000.0,"HeldToMaturitySecuritiesCurrent_0_Q2_USD":79148000.0,"LiabilitiesNoncurrent_0_Q2_USD":144058000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1700000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16346000.0,"HeldToMaturitySecuritiesNoncurrent_0_Q2_USD":97490000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":25147000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":3692000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4523000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":13679000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":48.62,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":18370000.0,"ShareBasedCompensation_2_Q2_USD":23502000.0,"Assets_0_Q2_USD":756795000.0,"CommonStockSharesIssued_0_Q2_shares":104020000.0,"EquitySecuritiesFvNi_0_Q2_USD":125793000.0,"FurnitureAndFixturesGross_0_Q2_USD":1022000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4624000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2632000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":7734000.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":586757000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":1524000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4649000.0,"DepreciationAndAmortization_2_Q2_USD":3766000.0,"MarketableSecuritiesCurrent_0_Q2_USD":125793000.0,"CommonStockValue_0_Q2_USD":196000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-193000.0,"AccountsReceivableNetCurrent_0_Q2_USD":955000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-110000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1043000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2271000.0,"PrepaidExpenseCurrent_0_Q2_USD":6639000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":103867000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":103303000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":1700000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q2_USD":66000.0,"EarningsPerShareBasic_1_Q2_USD":-0.26,"EarningsPerShareBasic_2_Q2_USD":-0.46,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":37479000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":20.06,"DepreciationDepletionAndAmortization_2_Q2_USD":2900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":10.64,"DepreciationDepletionAndAmortization_1_Q2_USD":1500000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":44697000.0,"OperatingLeaseLiability_0_Q2_USD":23800000.0,"CapitalizedComputerSoftwareGross_0_Q2_USD":599000.0,"HeldToMaturitySecurities_0_Q2_USD":176638000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":996645000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":47545000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":22528000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":372377000.0,"OtherAssetsNoncurrent_0_Q2_USD":265000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":400000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":850000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1530000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26914000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-47466000.0,"OtherAssetsCurrent_0_Q2_USD":1845000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":7735000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":81251000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1740000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2213000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":54113000.0,"LiabilitiesCurrent_0_Q2_USD":167188000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4522000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":103867000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":103303000.0,"LeaseholdImprovementsGross_0_Q2_USD":33107000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":224951000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-96000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":84000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":15359000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":23502000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":28.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":108149.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-26818000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-47550000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":19222000.0,"AccountsPayableCurrent_0_Q2_USD":5299000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1700000.0,"NonoperatingIncomeExpense_2_Q2_USD":4735000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.866,"NetIncomeLoss_2_Q2_USD":-47550000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":39400000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":135141412.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":180114000.0,"OperatingLeasePayments_2_Q2_USD":1400000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":14513000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":819668.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":445549000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":372377000.0,"ShortTermLeaseCost_1_Q2_USD":0.0,"ShortTermLeaseCost_2_Q2_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.085,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q2_USD":3542000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":7735000.0,"NonoperatingIncomeExpense_1_Q2_USD":1414000.0,"CommonStockSharesAuthorized_0_Q2_shares":145000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1700000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.46,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":900000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1272000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":58622000.0,"CapitalUnitsAuthorized_0_Q2_shares":150000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2859000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":756795000.0,"OperatingLeaseCost_1_Q2_USD":1100000.0,"OperatingLeaseCost_2_Q2_USD":2000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.44,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":65.41,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":144879000.0,"OperatingIncomeLoss_1_Q2_USD":-28232000.0,"OperatingIncomeLoss_2_Q2_USD":-52285000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":32811000.0,"OperatingExpenses_2_Q2_USD":106398000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.26,"OperatingExpenses_1_Q2_USD":61043000.0,"ProfitLoss_2_Q2_USD":-47550000.0,"CommonStockSharesOutstanding_0_Q2_shares":104019546.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":109000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":228794000.0,"MarketableSecurities_0_Q2_USD":125800000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-551394000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2426786.0,"VariableLeaseCost_1_Q2_USD":200000.0,"VariableLeaseCost_2_Q2_USD":500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3779586.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-497000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":11437000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":121530000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":78000000.0,"OtherLiabilitiesCurrent_0_Q2_USD":17000.0,"ProfitLoss_1_Q2_USD":-26818000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2400000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":247118000.0,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]